AmerisourceBergen (Cencora Inc.) (NYSE: COR)
Medical Distribution · Conshohocken, PA, United States · Founded 2001
- Market capitalization: $45.0 billion
- Annual revenue: $321.33 billion
- Net income: $1.55 billion
- Employees: 46,000
- Sector: Healthcare
- Headquarters: Conshohocken, United States
- Founded: 2001
Source: Statvoo company profile for AmerisourceBergen (Cencora Inc.). Browse all 500+ companies
Cencora, formerly AmerisourceBergen, is one of the three largest pharmaceutical distributors in the United States, alongside McKesson and Cardinal Health. The company rebranded to Cencora in 2023 to reflect its expanding global footprint and services beyond traditional drug distribution. Cencora provides pharmaceutical distribution, specialty drug services, and global commercialization solutions to manufacturers, pharmacies, and healthcare providers.
Cencora earns revenue from pharmaceutical distribution margins, specialty pharmacy services, and global manufacturer services that help drug companies commercialize and distribute their products. The specialty drug segment, which handles high-cost biologics and oncology drugs, carries higher margins than generic distribution.
AmerisourceBergen was formed in 2001 through the merger of AmeriSource Health and Bergen Brunswig. The company rebranded to Cencora in 2023. The acquisition of Alliance Healthcare in 2021 for $6.5 billion significantly expanded Cencora's international presence, particularly in Europe. Like its peers, Cencora has faced opioid litigation, agreeing to a $6.4 billion settlement.
| Market Capitalization | $45.0B |
| Annual Revenue | $321.33B |
| Net Income | $1.55B |
| Profit Margin | 0% |
| Revenue per Employee | $6985435K |
| Stock Exchange | NYSE |
| Ticker Symbol | COR |
Financial data is approximate and based on most recent annual filings.
Cencora's specialty distribution business handles some of the most expensive drugs in the world, including gene therapies costing over $1 million per treatment. The company distributes pharmaceuticals to over 150 countries through its global network.
Cencora's specialty drug focus gives it the best margin profile among the Big Three distributors. The international expansion through Alliance Healthcare is a differentiator, and the growing complexity of specialty drug distribution plays directly to the company's strengths.
What is AmerisourceBergen (Cencora Inc.)'s revenue?
AmerisourceBergen (Cencora Inc.) generates approximately $321.33 billion in annual revenue.
How many employees does AmerisourceBergen (Cencora Inc.) have?
AmerisourceBergen (Cencora Inc.) employs approximately 46,000 people worldwide.
What is AmerisourceBergen (Cencora Inc.)'s market cap?
AmerisourceBergen (Cencora Inc.) (COR) has a market capitalization of approximately $45.0 billion on the NYSE.
When was AmerisourceBergen (Cencora Inc.) founded?
AmerisourceBergen (Cencora Inc.) was founded in 2001 and is headquartered in Conshohocken, PA, United States.
Who is the CEO of AmerisourceBergen (Cencora Inc.)?
Robert Mauch is the current CEO of AmerisourceBergen (Cencora Inc.).
What is AmerisourceBergen (Cencora Inc.)'s website?
AmerisourceBergen (Cencora Inc.)'s official website is cencora.com.
| CEO | Robert Mauch |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Founded | 2001 |
| HQ | Conshohocken, PA |
| Country | United States |
| Website | cencora.com |
See traffic, security, and technical data for AmerisourceBergen (Cencora Inc.)'s website:
📊 cencora.com stats 📋 WHOIS 🌐 DNS 🔒 SSL